About: Claude H. Nash

An Entity of Type: person, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Claude H. Nash (born 1943) was CEO of Bloodstone Ventures plc. from 2007 to 2010. From 2004 to 2006 he was vice president, research and development at the University of Maryland Biotechnology Institute. He previously cofounded, and was CEO and chairman of, ViroPharma Incorporated, a pharmaceutical company. Before founding ViroPharma, Nash was vice president of infectious disease and cancer research at the Schering-Plough Research Institute.

Property	Value
dbo:abstract	Claude H. Nash (born 1943) was CEO of Bloodstone Ventures plc. from 2007 to 2010. From 2004 to 2006 he was vice president, research and development at the University of Maryland Biotechnology Institute. He previously cofounded, and was CEO and chairman of, ViroPharma Incorporated, a pharmaceutical company. Before founding ViroPharma, Nash was vice president of infectious disease and cancer research at the Schering-Plough Research Institute. (en)
dbo:wikiPageID	3452315 (xsd:integer)
dbo:wikiPageLength	3041 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1120057693 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Cancer dbr:New_Drug_Application dbr:Biochemistry dbr:Biology dbr:ViroPharma dbr:Investigational_New_Drug dbc:Living_people dbr:Colorado_State_University dbr:Common_cold dbr:Eli_Lilly_and_Company dbr:Sigma_Xi dbr:Sterling_Drug dbc:1943_births dbc:American_biochemists dbc:Businesspeople_in_the_pharmaceutical_industry dbc:Fellows_of_the_American_Academy_of_Microbiology dbr:Exton,_Pennsylvania dbr:Chemistry dbc:Businesspeople_from_Pennsylvania dbc:Lamar_University_alumni dbc:Eli_Lilly_and_Company_people dbr:Lamar_University dbr:Phi_Kappa_Phi dbr:Pleconaril dbr:Schering_Plough dbr:Initial_public_offering dbr:Microbiology dbr:Infectious_disease dbr:University_of_Maryland_Biotechnology_Institute dbr:SmithKline_Beecham dbr:Adolor_Corporation dbr:Society_for_Industrial_Microbiology dbr:ViroPharma_Incorporated dbr:Charles_Porter_Award
dbp:wikiPageUsesTemplate	dbt:Authority_control dbt:BLP_sources dbt:Reflist
dct:subject	dbc:Living_people dbc:1943_births dbc:American_biochemists dbc:Businesspeople_in_the_pharmaceutical_industry dbc:Fellows_of_the_American_Academy_of_Microbiology dbc:Businesspeople_from_Pennsylvania dbc:Lamar_University_alumni dbc:Eli_Lilly_and_Company_people
gold:hypernym	dbr:CEO
rdf:type	owl:Thing dbo:Person yago:WikicatAmericanBiochemists yago:WikicatLamarUniversityAlumni yago:WikicatLivingPeople yago:WikicatPeopleFromPennsylvania yago:Alumnus109786338 yago:Biochemist109854915 yago:CausalAgent100007347 yago:Chemist109913824 yago:Intellectual109621545 yago:LivingThing100004258 yago:Object100002684 yago:Organism100004475 yago:Person100007846 yago:PhysicalEntity100001930 yago:YagoLegalActor yago:YagoLegalActorGeo yago:Scholar110557854 yago:Scientist110560637 yago:Whole100003553
rdfs:comment	Claude H. Nash (born 1943) was CEO of Bloodstone Ventures plc. from 2007 to 2010. From 2004 to 2006 he was vice president, research and development at the University of Maryland Biotechnology Institute. He previously cofounded, and was CEO and chairman of, ViroPharma Incorporated, a pharmaceutical company. Before founding ViroPharma, Nash was vice president of infectious disease and cancer research at the Schering-Plough Research Institute. (en)
rdfs:label	Claude H. Nash (en)
owl:sameAs	freebase:Claude H. Nash yago-res:Claude H. Nash wikidata:Claude H. Nash https://global.dbpedia.org/id/4hgc6
prov:wasDerivedFrom	wikipedia-en:Claude_H._Nash?oldid=1120057693&ns=0
foaf:isPrimaryTopicOf	wikipedia-en:Claude_H._Nash
is dbo:foundedBy of	dbr:ViroPharma
is dbo:wikiPageRedirects of	dbr:Claude_H_Nash
is dbo:wikiPageWikiLink of	dbr:ViroPharma dbr:Nash_(surname) dbr:Claude_H_Nash dbr:List_of_Lamar_University_alumni dbr:Lamar_University dbr:Society_for_Industrial_Microbiology_and_Biotechnology
is foaf:primaryTopic of	wikipedia-en:Claude_H._Nash